BioEclipse Therapeutics, Inc.
Biotechnology company · South San Francisco, California, United States
BioEclipse Therapeutics, Inc. is a biotechnology company headquartered in South San Francisco, California, United States. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2019.
Profile compiled from public records. Is this your company? Request a correction or update
BioEclipse Therapeutics at a glance
Typebiotechnology company
HeadquartersSouth San Francisco, California, United States
SEC CIK1780708
What does BioEclipse Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $10.1 million sold (2019).
Frequently asked questions about BioEclipse Therapeutics
Where is BioEclipse Therapeutics headquartered?
BioEclipse Therapeutics, Inc. is headquartered in South San Francisco, California, United States.
What does BioEclipse Therapeutics do?
BioEclipse Therapeutics, Inc. is a biotechnology company.
Similar companies
- Alector, Inc.South San Francisco, California, United States
- Vaxart, Inc.South San Francisco, California, United States
- Denali Therapeutics Inc.South San Francisco, California, United States
- Aligos Therapeutics, Inc.South San Francisco, California, United States
- PROFUSA, Inc.South San Francisco, California, United States
- Quince Therapeutics, Inc.South San Francisco, California, United States
- Allogene Therapeutics, Inc.South San Francisco, California, United States
- Sutro Biopharma, Inc.South San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences